As the radiopharmaceuticals market is booming, the market size is expected to soar to $26.51 Billion by 2031. In a fast expanding field, keeping up the pace for novel target mining, selection and cutting edge drug design requires expert capabilities, innovative technologies and custom services to transform radiopharmaceutical drug discovery.

The inaugural TRP Target Selection & Drug Design Summit is bringing together the field’s expert drug hunters from senior-decision makers in medicinal chemistry, discovery, R&D, biology, radiochemistry, strategy and more. Actively seeking high level support and services from preclinical CRO capabilities and assays, radioconjugation, proteomics & machine learning for target mining, targeting molecule development and isotope supply to maximize the therapeutic index of their radiopharmaceuticals.